Atossa Therapeutics shares rise after FDA grants orphan drug designation for soft tissue sarcoma
Atossa Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $5.11
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS